195 related articles for article (PubMed ID: 10626264)
1. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus.
Bolli GB
J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264
[No Abstract] [Full Text] [Related]
2. [Documented advantages of insulin Lantus when compared with NPH insulin].
Frid A
Lakartidningen; 2004 Sep; 101(39):3014. PubMed ID: 15493644
[No Abstract] [Full Text] [Related]
3. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
Bell DS; Ovalle F; Shadmany S
Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
[No Abstract] [Full Text] [Related]
4. [New insulin with uniform action. Hazards of blood sugar variations minimized].
MMW Fortschr Med; 2003 Oct; 145(40):55. PubMed ID: 14603609
[No Abstract] [Full Text] [Related]
5. Insulin delivery devices--pumps and pens.
Hirsch IB
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S115-6. PubMed ID: 20515300
[No Abstract] [Full Text] [Related]
6. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
Al Shamsi AM
Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
[No Abstract] [Full Text] [Related]
7. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
Bolli GB
Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
[TBL] [Abstract][Full Text] [Related]
8. The journey to metabolic control in diabetes: many more miles to go.
Silverstein JH; Rosenbloom AL
J Pediatr; 2003 Dec; 143(6):704-6. PubMed ID: 14657811
[No Abstract] [Full Text] [Related]
9. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
10. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
[TBL] [Abstract][Full Text] [Related]
11. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
[TBL] [Abstract][Full Text] [Related]
12. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
Päivärinta M; Tapanainen P; Veijola R
Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
[TBL] [Abstract][Full Text] [Related]
13. Human insulin-induced lipoatrophy.
Felner EI
J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
[No Abstract] [Full Text] [Related]
14. [Insulin treatment in children].
Birkebaek NH; Hertz B; Olsen BS
Ugeskr Laeger; 2009 Jun; 171(23):1919-22. PubMed ID: 19500514
[TBL] [Abstract][Full Text] [Related]
15. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
16. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.
Robertson KJ; Schoenle E; Gucev Z; Mordhorst L; Gall MA; Ludvigsson J
Diabet Med; 2007 Jan; 24(1):27-34. PubMed ID: 17227321
[TBL] [Abstract][Full Text] [Related]
17. Rational use of insulin analogues in the treatment of type 1 diabetes mellitus.
Bolli GB
Pediatr Endocrinol Rev; 2003 Sep; 1(1):9-21. PubMed ID: 16437009
[TBL] [Abstract][Full Text] [Related]
18. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
19. Are you up to date on diabetes medications?
Kestel F
Am J Nurs; 1994 Jul; 94(7):48-52. PubMed ID: 8017497
[No Abstract] [Full Text] [Related]
20. [Long-acting insulin analogs: progressing slowly].
Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
